Singaporean Biotech Startup Gero Raises US$2.2M Series A To Deliver Anti-Aging Solutions
Gero’s Series A will help further develop the proprietary AI platform to identify treatments for aging-related and other diseases Singapore-based Biotech startup Gero, which develops new drugs for aging and other disorders using artificial intelligence (AI), has secured US$2.2 million in a Series A funding round led by Belarus-based Bulba Ventures, with participation from previous […]
Singaporean Biotech Startup Gero Raises US$2.2M Series A To Deliver Anti-Aging Solutions Read More »
Gero’s Series A will help further develop the proprietary AI platform to identify treatments for aging-related and other diseases Singapore-based Biotech startup Gero, which develops new drugs for aging and other disorders using artificial intelligence (AI), has secured US$2.2 million in a Series A funding round led by Belarus-based Bulba Ventures, with participation from previous

